Czech J. Anim. Sci., 2010, 55(2):83-88 | DOI: 10.17221/195/2009-CJAS

The influence of prolactin on bone mineral density (BMD) and some biochemical markers of ovariectomized rats

B. Dolińska1, A. Suszka-Świtek2, S. Dragan3, F. Ryszka1, R. Kołacz4, B. Patkowska-Sokoła4
1 Pharmaceutical Scientific - Production Plant Biochefa, Poland
2 Medical University of Silesia, Katowice, Poland
3 Wroclaw Medical University, Wroclaw, Poland
4 Wroclaw University of Environmental and Life Sciences, Wroclaw, Poland

A model of postmenopausal osteoporosis was used in the study. 107 days after ovariectomy the animals were subcutaneously applied 1.0 IU PRL/kg BM or 1.0 IU calcitonin/kg BM for 7 days in single doses. The application of the preparations started again 80 days after the first application. After 194 days the animals were narcotized, blood was collected, and lumbar (L2-L4) and femoral bones were prepared. The material obtained was subjected to densitometric analysis of bone mineral density (BMD). In ovariectomized rats the loss of osseous tissue was observed only in the lumbar bone. The application of prolactin to ovariectomized rats caused an increase in the mineral density of the lumbar bone up to a BMD value equal to that of the control group which had not been subjected to ovariectomy (control healthy group - SHAM). Similar results were obtained in the case of calcitonin. An increase in osteocalcin concentration and activity of isoenzyme alkaline phosphatase (BAL), with a decrease in the activity of isoenzyme acid phosphatase (TRAP) was observed in experimental groups compared to control ones.

Keywords: prolactin (PRL); ovariectomy; experimental osteoporosis; bone mineral density (BMD); lumbar bone (L2-L4); femoral bone; female rats

Published: February 28, 2010  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Dolińska B, Suszka-Świtek A, Dragan S, Ryszka F, Kołacz R, Patkowska-Sokoła B. The influence of prolactin on bone mineral density (BMD) and some biochemical markers of ovariectomized rats. Czech J. Anim. Sci. 2010;55(2):83-88. doi: 10.17221/195/2009-CJAS.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Adler R.A., Evani R., Mansouri A. (1998): Relative effects of prolactin excess and estrogen deficiency on bone in rats. Metabolism, 47, 425-428. Go to original source... Go to PubMed...
    2. Briot K., Cortet B., Tremollieres F., Sutter B., Thomas T., Roux Ch., Audran M. (2009): Male osteoporosis: Diagnosis and fracture risk evaluation. Joint Bone Spine, 76, 129-133 Go to original source... Go to PubMed...
    3. Compston J., Cooper A., Cooper C., Francis R., Kanis J.A., Marsh D., McCloskey E.V., Reid D.M., Selby P., Wilkins M. (2009): Guidelines for the diagnosis and management of osteoporosis in postmenopausal women and men from the age of 50 years in the UK. Maturitas, 62, 105-108. Go to original source... Go to PubMed...
    4. Delaney M. (2006): Strategies for the prevention and treatment of osteoporosis during early postmenopause. American Journal of Obstetrics and Gynecology, 194, 12-23. Go to original source... Go to PubMed...
    5. Dróżdż M., Ryszka F., Pardela M. (1998): Prolactin (PRL) - a review of current and new perspectives of clinical use. Medical Science Monitor, 4, 191-194.
    6. International Conference on Harmonization (ICH) (2006): Guide for Industry. Q2B. Validation of Analytical Procedures: Methodology, 1996. Available at: http://www.fda.gov/cder/guidance/index.htm
    7. Kalu D.N. (1991): The ovariectomized rats as an animal model for postmenopausal bone loss. Bone Miner, 15, 175-92. Go to original source... Go to PubMed...
    8. Kamel H.K. (2007): Update on osteoporosis management in long-term care: focus on bisphosphonates. Jamda, 8, 434-440. Go to original source... Go to PubMed...
    9. Krishnamara N., Taweerathitan P. (1995): Acute effect of prolactin on active calcium absorption in rats. Canadian Journal of Physiology and Pharmacology, 73, 1185-1189. Go to original source... Go to PubMed...
    10. Krishnamara N., Lotinum S., Limlomwongse L. (1993): Acute effect and mechanism of action of prolactin on the in situ passive calcium absorption in rat. Bone and Mineral, 23, 253-66. Go to original source... Go to PubMed...
    11. Krishnamara N., Seemoung Limlomwongse L. (1997): Acute effect of prolactin on bone 45Ca accumulation in rats. Endocrine Journal, 44, 257-264. Go to original source... Go to PubMed...
    12. MengYong Z., Caijiao W., HuSheng Z., XianWu P., JinaMin F. (2008): Protective effect of polysaccharides from morinda officinalis on bone loss in ovariectomized rats. International Journal of Biological Macromolecules, 43, 276-278. Go to original source... Go to PubMed...
    13. Mortensen B., Gordeladze J.O., Haug E., Schjerven L., Gautvik K.M. (1993): Relationship between circulating vitamin D 3 metabolites and prolactin or growth hormone levels in rat. Pharmacol-Toxicol, 72, 188-193. Go to original source... Go to PubMed...
    14. Nicoll C.S. (1980): Ontogeny and evaluation of prolactin's function. Federation Proceedings, 39, 2563-2570.
    15. Peng Z.Q., Vaananen H.K., Zhang H.X., Tuukkanen J. (1997): Long-term effect of ovariectomy on the mechanical properties and chemical composition of rat bone. Bone, 20, 207-212. Go to original source... Go to PubMed...
    16. Pinkerton J.V., Dalkin A.C. (2007): Combination therapy for treatment of osteoporosis: a review. American Journal of Obstetrics, 10, 559-565. Go to original source... Go to PubMed...
    17. Roux C., Kolta S., Chappard C., Morieux C., Dougados M., De Vernejoul M.C. (1996): Bone effect of dydrogestrone in ovariectomized rats: a biologic, histomorphometric and densitometric study. Bone, 19, 463-468. Go to original source... Go to PubMed...
    18. Ryszka F., Krupej J., Dolińska B. (1995): Biological accessibility and distribution of calcitonin in rats with experimental osteoporosis. Pharmazie, 9, 636-637.
    19. Ryszka F., Dolińska B., Suszka-Świtek A. (2002): Distribution of prolactin in selected rat organs and tissues. International Journal of Tissue Reactions, 1, 99-102.
    20. Scotti M.L., Langenheim J.F., Tomblyn S., Springs A.E.B., Chen W.Y. (2008): Additive effects of a prolactin receptor antagonist, G129R, and herceptin on inhibition of HER2-overexpressing breast cancer cells. Breast Cancer Research and Treatment, 111, 241-250. Go to original source... Go to PubMed...
    21. Tanrattana Ch., Charoenphandhu N., Limlomwongse L., Krishnamra N. (2004): Prolactin directly stimulated the solvent drag-induced calcium transport in the duodenum of female rats. Biochimica and Biophysica Acta, 1665, 81-91. Go to original source... Go to PubMed...
    22. Wang F., Roberts S.M., Butfiloski E.J., Sobel E.S. (2007): Diminished prolactin from chlordecone treatment in ovariectomized (NZB × NZW)F1 mice. International Immunopharmacology, 7, 1808-1812. Go to original source... Go to PubMed...

    This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International (CC BY NC 4.0), which permits non-comercial use, distribution, and reproduction in any medium, provided the original publication is properly cited. No use, distribution or reproduction is permitted which does not comply with these terms.


    Return to the content